Efficacy and Safety of Parathyroid Hormone Replacement With TransCon PTH in Hypoparathyroidism: 26‐Week Results From the Phase 3 PaTHway Trial
暂无分享，去创建一个
C. Sibley | L. Rejnmark | C. Marcocci | M. Rubin | D. Shoback | B. Clarke | Susanne Pihl | A. Palermo | T. Vokes | Aliya A. Khan | C. Gagnon | L. Kohlmeier | A. Shu | P. Schwarz | L. Hofbauer | Xuebei An | J. Ukena | Lisa G Abbott | Walter Frank Eng | Alden R Smith | B. Clarke